Cardinal Health Extends CVS Health Distribution Deal Through 2032 and Backs Full-Year Guidance

Cardinal Health secured an extension of its pharmaceutical distribution agreement with CVS Health through 2032, a renewal that sent CAH shares notably higher on October 1. The deal ensures Cardinal Health remains a primary drug distribution partner for one of the largest pharmacy chains in the United States, locking in a major revenue stream well into the next decade.

McKesson also extended its own distribution agreement with CVS Health on the same day, meaning CVS split its business between the two wholesalers rather than consolidating with a single distributor. The parallel announcements underscored the scale of CVS's distribution needs and the competitive but shared nature of the pharmaceutical wholesale market.

Alongside the CVS news, Cardinal Health reaffirmed its fiscal year guidance, signaling confidence that the renewed contract aligns with its existing financial outlook. The company also announced it will report first-quarter fiscal year 2027 results on November 5, giving investors a near-term catalyst to watch for updated performance figures.